Search Results 141-150 of 430 for ❣베스트토토검증【평생베스트.com】베스트토토❣

  1. A Study to Develop and Validate Clinical Molecular Genetic Lab Tests for the Confirmation of Biochemical Genetic Test Results - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 08-004662. Sponsor Protocol Number: 08-004662. About this study. The aim of this research study is to develop ...

  2. Wisconsin Registry for Alzheimer's Prevention - Mayo Clinic

    ... best. Study IDs. Site IRB. La Crosse, Wisconsin: 12-005761. Sponsor Protocol Number: AG027161. About this study. The purpose of this study is to identify ...

  3. A Study of Disease Prediction for NOTCH3 - Mayo Clinic

    ... best. Study IDs. Site IRB. Jacksonville, Florida: 24-013764. About this study. The purpose of this study is to assess NOTCH3-SVD disease progression and develop ...

  4. Zhen Wang, Ph.D. - Mayo Clinic Faculty Profiles

    Zhen Wang, Ph.D., studies how current best medical evidence can be used to help patients, health care providers, policy makers and researchers make informed ...

  5. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  6. Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or In Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  7. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  8. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. A Study of XmAb ®18087 in Subjects With NET and GIST - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  10. Ankle-brachial index - Mayo Clinic

    The ankle-brachial index test is a quick, simple way to check for peripheral artery disease (PAD). The disease happens when narrowed arteries reduce the ...